National Health Investors, Inc. (NYSE: NHI) is a Real Estate company (REIT - Healthcare Facilities) with a market capitalization of $2.9B. The Maz Rating grades it against the other companies in its sector.
About three months ago (August 17, 2026), National Health Investors, Inc. had a Maz Rating of 3.07 out of 5 (B+, Buy), ranked against the other companies in its sector. Its strongest factor then was Profitability (4.86), among the strongest in its sector; its weakest was Valuation (1.96), more expensive than most of its sector. The other factors: Financial Health 4.15 (above most of its sector); Growth 3.28 (around the middle of its sector); Momentum 2.09 (below most of its sector). The current rating is for members: log in to see it.
At $59.98, National Health Investors, Inc. trades at 4.2x trailing earnings, 6.4x sales and 1.4x book value, with an EV/EBITDA of 4.6. Over the last twelve months it generated about $460M of revenue and $704M of net income. It runs a gross margin of 50.6%, an operating margin of 39.9% and a net margin of 152.5%. It shows return on equity of 41.7%, return on invested capital of 5.8% and a free cash flow yield of 7.0%. On the balance sheet: a debt-to-equity ratio of 0.50 and a current ratio of 3.08. Over the past 52 weeks the share price ranged from $59.05 to $91.38, with a beta of 0.53.
National Health Investors, Inc. pays a dividend yielding 6.20%, with 26% of earnings paid out.
19 Wall Street analyst ratings cover the stock: 6 Buy, 12 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.